Company
Schrödinger ($SDGR)
Description
Develops a physics-based computational platform to discover, optimize, and formulate molecules and materials for drug discovery teams and materials science researchers.
Related
Center for Nanophase Materials Sciences (CNMS)Operates a laboratory center supporting nanophase materials research and development, helping researchers discover and design materials for…
Schmidt SciencesSupports researchers, centers, fellowships, and scientific outputs in AI, space, biosciences, climate, and science systems to advance…
Isomorphic LabsBuilds predictive and generative AI models for drug discovery, used to accelerate scientific discovery and design novel molecules for…
Genesis TherapeuticsBuilds molecular AI models and a design platform to optimize small-molecule drug discovery and create new medicines for partners and…
QC WareBuilds quantum computing software and services, including molecular simulation and AI tools for drug discovery teams tackling computational…
Curia (formerly AMRI)Provides CDMO services for drug discovery, development, and manufacturing, supporting pharmaceutical clients with small molecules, generic…
IktosIktos develops an AI-driven platform for drug discovery. It supports molecule design, retrosynthesis, robotic synthesis, analysis, testing,…
Mirror Physics CorporationDevelop AI-driven drug discovery software, providing tools for conformer generation, docking preparation, virtual screening, ADMET…
COMSOL ABDevelops mathematical modeling and simulation software; used by engineers, researchers, and lecturers to create physics-based models,…
BYTELAB SOLUTIONS SLBuilds computational chemistry software and in silico testing tools for R&D teams; used by specialty-chemicals researchers and enterprises…
Relation TherapeuticsBuilds AI-driven drug discovery and development platforms to identify biology and advance molecules to clinical value inflection points for…
Numerion LabsBuilds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for…